There is debate regarding the etiology of central serous chorioretinopathy in systemic lupus erythematosus. The increased permeability of the choroid may be a result of the systemic immune process or ...

In this interventional non-randomized clinical study, 27 treatment-naive CSC patients were prospectively enrolled and treated with oral eplerenone for 5–13 weeks. Primary outcomes included presence of ...

The patients presenting with long-standing CSC, but without the features of chronicity, were offered the options of TTT, photodynamic therapy (for subfoveal leaks), photocoagulation (for extrafoveal ...

Hypertension, Helicobacter pylori infection, steroid use, sleep disturbances, autoimmune disease, psychopharmacologic medication use, and type A behavior are possible risk factors for central serous ...

KOLOA, Hawaii — Lack of a consensus classification, overlapping pathophysiologic explanations and controversy over treatment make central serous chorioretinopathy “scream inducing,” according to a ...

Background To determine the efficacy of high-dose antioxidants in the acute stage of central serous chorioretinopathy (CSC). Methods This was a randomized placebo-controlled study. The patients with ...

Central serous retinopathy (CSR) does not cause macular degeneration. Both are distinct eye conditions that affect the choroid and retina, and a specialist can determine which a person has. CSR, also ...